Financials
- Market Capitalization 1.62 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.86
市销率
18.95
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2142 | ANAB AnaptysBio, Inc. - Common Stock | 56.71 USD | -9.28% | -13.31% | -5.48% | +61.11% | 1.65 B USD | ||
| 2145 | INVA Innoviva, Inc. - Common Stock | 21.94 USD | +0.92% | -1.92% | -4.48% | +23.12% | 1.62 B USD | ||
| 2168 | ABSI Absci Corporation - Common Stock | 9.88 USD | -3.42% | -6.79% | +35.53% | +275.67% | 1.54 B USD | ||
| 2176 | AVBP ArriVent BioPharma, Inc. - Common Stock | 32.64 USD | +0.31% | -1.54% | +7.37% | +49.86% | 1.52 B USD |